Status:
COMPLETED
UH3 Phase - Mindfulness-Based Blood Pressure Reduction (MB-BP) : Stage 2a RCT
Lead Sponsor:
Brown University
Collaborating Sponsors:
National Institutes of Health (NIH)
National Center for Complementary and Integrative Health (NCCIH)
Conditions:
Hypertension
Prehypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary aim is to identify the impacts of a behavioral intervention called "Mindfulness-Based Blood Pressure Reduction" (MB-BP) vs. enhanced usual care on the primary self-regulation target, speci...
Detailed Description
Effects of mindfulness interventions customized for prehypertensive/hypertensive patients are poorly understood. Until methodologically rigorous studies to evaluate customized interventions for hypert...
Eligibility Criteria
Inclusion
- Elevated blood pressure or hypertension defined as ≥120 mmHg systolic or ≥80 mmHg diastolic pressure.
- Able to speak, read, and write in English.
- All adults (≥18 years of age), genders and racial/ethnic groups are eligible to be included.
Exclusion
- Exclusion criteria follow standard guidelines and recommendations:
- current regular mindfulness meditation practice (\>once/week)
- serious medical illness or cognitive condition (e.g., dementia) precluding regular class attendance and/or participation
- current substance abuse, suicidal ideation or eating disorder
- history of bipolar or psychotic disorders or self-injurious behaviors.
Key Trial Info
Start Date :
December 13 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 12 2020
Estimated Enrollment :
119 Patients enrolled
Trial Details
Trial ID
NCT03859076
Start Date
December 13 2018
End Date
November 12 2020
Last Update
January 13 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brown Mindfulness Center
Providence, Rhode Island, United States, 02903